Open access
Sep 2026
A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma
(GPRC5D) is a leading immunotherapy target in multiple myeloma (MM), with diverse GPRC5D-targeting agents — including T-cell engagers (TCE), antibody – drug conjugates
Ricardo Ahrens, K. Ahrens, Maximilian Al-Bazaz et al.
· Blood Cancer Journal · 0 citations